These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Small molecule inhibitors in children with malignant gliomas. Herrington B; Kieran MW Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732 [TBL] [Abstract][Full Text] [Related]
4. DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Frosina G Mol Cancer Res; 2009 Jul; 7(7):989-99. PubMed ID: 19609002 [TBL] [Abstract][Full Text] [Related]
5. Autophagy: a strategy for malignant gliomas' resistance to therapy. Ge P; Luo Y; Fu S; Ji X; Ling F Med Hypotheses; 2009 Jul; 73(1):45-7. PubMed ID: 19268486 [TBL] [Abstract][Full Text] [Related]
7. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
8. The role of cytotoxic drugs in the treatment of central nervous system gliomas. Neyns B; D'haeseleer M; Rogiers A; Van de Cauter J; Chaskis C; Michotte A; Strik H Acta Neurol Belg; 2010 Mar; 110(1):1-14. PubMed ID: 20514922 [TBL] [Abstract][Full Text] [Related]
11. [Cancer stem cells in malignant glioma-the mechanism of cancer initiation and the therapeutic development]. Nakano I; Saya H No Shinkei Geka; 2010 Oct; 38(10):879-89. PubMed ID: 21041889 [TBL] [Abstract][Full Text] [Related]
12. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors. Gilg AG; Tye SL; Tolliver LB; Wheeler WG; Visconti RP; Duncan JD; Kostova FV; Bolds LN; Toole BP; Maria BL Clin Cancer Res; 2008 Mar; 14(6):1804-13. PubMed ID: 18347183 [TBL] [Abstract][Full Text] [Related]
13. Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential. Chistiakov DA; Chekhonin VP Eur J Pharmacol; 2012 Jun; 684(1-3):8-18. PubMed ID: 22484336 [TBL] [Abstract][Full Text] [Related]
14. Editorial review: targets for glioma treatment: from bench to bedside. Sanson M Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046 [TBL] [Abstract][Full Text] [Related]
16. New developments in the treatment of malignant gliomas. Soffietti R; Leoncini B; Rudà R Expert Rev Neurother; 2007 Oct; 7(10):1313-26. PubMed ID: 17939769 [TBL] [Abstract][Full Text] [Related]
17. Neuropathological and molecular aspects of low-grade and high-grade gliomas. Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604 [TBL] [Abstract][Full Text] [Related]
18. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay. Glantz M; Kesari S; Recht L; Fleischhack G; Van Horn A Semin Oncol; 2009 Aug; 36(4 Suppl 2):S17-24. PubMed ID: 19660679 [TBL] [Abstract][Full Text] [Related]
19. Medical treatment of high grade malignant gliomas in adults: an overview. Brandes A; Soesan M; Fiorentino MV Anticancer Res; 1991; 11(2):719-27. PubMed ID: 2064325 [TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy of brain tumors]. Kuratsu J; Ushio Y Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():377-83. PubMed ID: 7986118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]